SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Ripple is the catchall name for the cryptocurrency platform, the transactional protocol for which is actually XRP, in the same fashion as Ethereum is the name for the platform that facilitates trades in Ether. Like other cryptocurrencies, Ripple is built atop the idea of a distributed ledger network which requires various parties to participate in validating transactions, rather than any singular centralized authority. That facilitates transactions all over the world, and transfer fees are far cheaper than the likes of bitcoin. Unlike other cryptocurrencies, XRP transfers are effectively immediate, requiring no typical confirmation time.  Ripple was originally founded by a single company, Ripple Labs, and continues to be backed by it, rather than the larger network of developers that continue bitcoin’s development. It also doesn’t have a fluctuating amount of its currency in existence. Where bitcoin has a continually growing pool with an eventual maximum, and Ethereum theoretically has no limit, Ripple was created with all of its 100 billion XRP tokens right out of the gate. That number is maintained with no mining and most of the tokens are owned and held by Ripple Labs itself — around 60 billion at the latest count.  Even at the recently reduced value of around half a dollar per XRP, that means Ripple Labs is currently sitting on around $20 billion worth of the cryptocurrency (note: Ripple’s price crashed hard recently, and may be worth far less than $60 billion by time you read this). It holds 55 billion XRP in an escrow account, which allows it to sell up to a billion per month if it so chooses in order to fund new projects and acquisitions. Selling such an amount would likely have a drastic effect on the cryptocurrency’s value, and isn’t something Ripple Labs plans to do anytime soon.  In actuality, Ripple Labs is looking to leverage the technology behind XRP to allow for faster banking transactions around the world. While Bitcoin and other cryptocurrencies are built on the idea of separating financial transactions from the financial organizations of traditional currencies, Ripple is almost the opposite in every sense.  XRP by Ripple price can be found on this page alongside the market capitalization and additional stats.

Ripple

XRP is gaining significant traction amid increasing anticipation for regulatory clarity, with community discussions centered on its potential for expanded institutional adoption and real-world utility. Recent news highlighting reduced exchange supply, potential integrations, and general market momentum are fueling widespread optimism, though some observers remain cautious about sustained independent upward movement.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is currently trending with immense community enthusiasm, driven by its multi-chain expansion across major ecosystems like Solana, Base, Cronos, and Ethereum. Investors are actively discussing its unique deflationary burn mechanism and its strong potential to become a leading meme coin, aligning with a vibrant counter-culture narrative to attract significant market volume.

Keeta is a high-performance layer-1 blockchain designed to unify transactions across different blockchains and fiat payment systems, eliminating the need for costly intermediaries, reducing fees, and enabling near-instant settlements. With 400-millisecond transaction finality and the ability to process 10 million transactions per second, Keeta sets a new industry benchmark for speed and scalability.  Founded in 2022 and backed by Eric Schmidt, the former CEO of Google, Keeta has been engineered to meet the stringent regulatory and operational requirements of financial institutions. Its advanced on-chain compliance protocols, including KYC and AML, ensure security and regulatory adherence. Keeta’s architecture natively supports asset tokenization and digital identity, making it an ideal platform for stablecoins and real-world asset transfers.  By facilitating cross-chain transactions and interoperability with existing payment systems, Keeta bridges the gap between cryptocurrencies and fiat, enabling a secure, efficient, and compliant global financial ecosystem.

Keeta

Keeta (KTA) is drawing significant attention for its high-performance, compliance-first infrastructure, recently boosted by a strategic integration offering seamless fiat on-ramps. The community is actively discussing its potential as an undervalued foundational layer, poised to become essential global financial plumbing for regulated settlement and cross-chain interoperability.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is actively trending as community sentiment is sharply divided following recent U.S. actions concerning Venezuela, with supporters celebrating a decisive move against Nicols Maduro, often linked to oil interests and national strength. Critics, however, are vocal about the intervention being a contentious distraction and questioning its legitimacy. Broader conversations also include the company's strategic ventures into fusion energy, sparking further debate among investors.

CleanSpark, Inc. is a bitcoin mining technology company, which engages in the management of data centers. Its operations include College Park, Norcross, Washington, Sandersville, Dalton, and Massena. The company was founded by S. Matthew Schultz and Bryan Huber on October 15, 1987 and is headquartered in Henderson, NV.

Cleanspark Inc

CleanSpark is gaining significant attention fueled by a strong Bitcoin rally and heightened anticipation for a major AI/High-Performance Computing deal announcement. Community discussions heavily feature the stock's substantial short interest, leading to widespread speculation about an impending short squeeze, even as some express skepticism regarding the timing and impact of its AI pivot. This blend of crypto momentum and a potential strategic shift defines current sentiment.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Vienna, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy (MSTR) is drawing significant attention amid renewed Bitcoin price momentum, intensifying debate over its unique corporate treasury strategy. Community sentiment is sharply divided: bulls anticipate a strong rebound, citing MSTR's undervaluation relative to its Bitcoin holdings and dismissing concerns around an imminent MSCI index review as FUD. Conversely, bears highlight persistent share dilution and the stock's underperformance, predicting further volatility and potential outflows should the index reclassification occur.

Exxon Mobil Corp. engages in the exploration, development, and distribution of oil, gas, and petroleum products. It operates through the following segments: Upstream, Energy Products, Chemical Products, and Specialty Products. The Upstream segment organizes the exploration of crude oil and natural gas. The Energy Products segment includes fuels, aromatics, and catalyst and licensing. The Chemical Products segment offers petrochemicals. The Specialty Products segment provides finished lubricants, basestocks and waxes, synthetics, and elastomers and resins. The company was founded by John D. Rockefeller in 1882 and is headquartered in Spring, TX.

Exxon Mobil Corp.

Exxon Mobil Corp

Exxon Mobil is currently trending amidst significant geopolitical developments concerning Venezuela's vast oil reserves, fueling widespread speculation about the potential for U.S. oil companies to re-engage with the region. The community is actively discussing expectations of increased profitability and a potential breakout from multi-year price consolidation, while also weighing the implications of potential crude supply changes.

Chevron Corp. engages in the provision of oil and gas energy solutions. It provides crude oil and natural gas, manufactures transportation fuels, lubricants, petrochemicals, and additives, and develops technologies that enhance business and the industry. It operates through the Upstream and Downstream segments. The Upstream segment consists of the exploration, development, and production of crude oil and natural gas, the liquefaction, transportation, and regasification associated with liquefied natural gas, the transporting of crude oil by major international oil export pipelines, the processing, transporting, storage, and marketing of natural gas, and a gas-to-liquids plant. The Downstream segment consists of the refining of crude oil into petroleum products, the marketing of crude oil and refined products, the transporting of crude oil and refined products by pipeline, marine vessel, motor equipment, and rail car, and the manufacturing and marketing of commodity petrochemicals and plastics for industrial uses and fuel & lubricant additives. The company was founded on September 10, 1879 and is headquartered in Houston, TX.

Chevron Corp.

Chevron is surging amid reports of significant geopolitical shifts in Venezuela, where the U.S. is signaling deep involvement in the nation's vast oil industry. As the only major American oil company currently operating there, the community is buzzing with speculation about Chevron's uniquely advantageous position. Investors foresee potential for substantial re-engagement with Venezuela's immense crude reserves, positioning Chevron as a key player in this evolving energy landscape.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending following its announced rebranding, strategic headquarters relocation to Florida, and recent significant orders in autonomous and counter-drone systems. Community sentiment is overwhelmingly bullish, fueled by comparisons to early growth stages of major tech stocks and anticipation of further government contracts in the rapidly expanding drone and defense industry. Investors are actively discussing strong upward momentum and the potential for a substantial short squeeze.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is actively trending as its voice AI technology sees increasing adoption across automotive and enterprise sectors, with high anticipation for potential announcements at upcoming tech conferences. The community is keenly focused on its strong balance sheet, substantial contractual backlog, and projected revenue growth, alongside significant short interest that could fuel a notable reversal following recent price action.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wednesday, 13 August 2025 08:30 AMTopic:&nbsp;<h4>Company Update</h4>&nbsp;TAMPA, FLORIDA / <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.accessnewswire.com/">ACCESS Newswire</a> / August 13, 2025 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics Health" or the "Company"), a leader in next-generation pharmaceutical distribution, digital prescription routing, and AI-powered hub fulfillment, today announced the launch of its Ripple Labs-powered XRP Implementation Program, giving independent pharmacies access to blockchain-based payments in the prescription drug space for the first time. The program enables pharmacies to pay for products and move funds instantly, more cost-effectively, and with full transparency-eliminating delays, high fees, and reliance on traditional banking and credit card networks. Wellgistics Health is among the first healthcare companies to implement an XRP-based payment solution at scale.The program operates in partnership with RxERP, a serialized pharmaceutical eCommerce and ERP (Enterprise Resource Planning) system that manages onboarding, transactions, and reporting for participating pharmacies. With Wellgistics already serving more than 6,500 independent pharmacies and over 200 manufacturers nationwide, the Company is well-positioned to accelerate adoption rapidly and at scale.Pharmacies can now enroll in the beta program at:<a target="_blank" rel="noopener noreferrer nofollow" href="https://pr.report/d8zp">https://wellgisticshealth.com/xrp-in-healthcare/</a>How Pharmacies Benefit from Using XRP<ul><li>Instant Settlement - Payments settle in seconds, not days</li><li>Lower Fees - Avoid credit card and bank transaction costs</li><li>24/7 Availability - No banking delays, even on weekends and holidays</li><li>Improved Cash Flow - Faster access to working capital and inventory restock</li><li>Real-Time Tracking - View and confirm payments instantly</li><li>No Intermediaries - Direct transactions between pharmacy and distributor</li></ul>"We've been impressed with the response so far," said Brian Norton, CEO of Wellgistics Health. "Independent pharmacy owners are far more forward-thinking than many realize. They see the power of blockchain and understand how transformative this will be as it scales across the industry. Our mission is to give pharmacies greater control, speed, and transparency in their financial operations."Technical Innovation and Blockchain IntegrationThe XRP Payment Program harnesses the speed, scalability, and low-cost infrastructure of the XRP Ledger to meet the unique demands of the pharmaceutical supply chain. Integrated with RxERP, the platform delivers real-time, encrypted, and fully compliant payment processing tailored for independent pharmacies, wholesalers and in the near future, manufacturers.Pharmacies and investors can learn more by downloading the Wellgistics Health XRP E-Book:<a target="_blank" rel="noopener noreferrer nofollow" href="https://pr.report/d8zq">https://wellgisticshealth.com/xrp-in-healthcare/</a>Regulatory Compliance and SecurityThe XRP Payment Program has been developed to meet or exceed healthcare and financial regulatory standards, including HIPAA and anti-money laundering (AML) requirements. The system provides secure, traceable transactions while safeguarding sensitive data and maintaining privacy at every stage.Next Phase: Manufacturer Onboarding and Direct-to-Patient (DTP) ProgramsFollowing the pharmacy rollout, Wellgistics Health will begin onboarding pharmaceutical manufacturers to the XRP platform-expanding capabilities for direct, on-chain transactions. The Company also plans to launch manufacturer-powered Direct-to-Patient (DTP) programs, allowing manufacturers to ship medications directly to patients' homes in collaboration with their community pharmacy and prescribing physicians to ensure clinical continuity and compliance."Pharmacies deserve a payment system as fast and responsive as the care they provide," said Tony Madsen, COO of Wellgistics Health. "While this first phase focuses on helping pharmacies pay for products more efficiently, it's just the start. Our vision is to make every aspect of pharmacy payments faster, clearer, and completely frictionless."About Wellgistics HealthWellgistics Health (NASDAQ: WGRX) delivers medications from manufacturer to patient-faster, smarter, and more affordably. Its integrated platform connects 6,500+ independent pharmacies and 200+ U.S. manufacturers, providing wholesale distribution, digital prescription routing, and AI-powered hub services such as eligibility, adherence, onboarding, prior authorization, and cash-pay fulfillment. As a PBM-agnostic alternative, Wellgistics Health offers compliant, end-to-end solutions that restore access, transparency, and trust in U.S. healthcare.About RxERPRxERP is the only serialized pharmaceutical ERP system designed specifically for independent pharmacies, wholesalers, and manufacturers. It delivers real-time financial, operational, and compliance tools-integrating blockchain, AI, and serialized inventory management to streamline operations and modernize the supply chain. RxERP is the platform partner managing the XRP Implementation Program with Wellgistics Health.Forward-Looking StatementsThis press release may contain forward-looking statements regarding Wellgistics Health's plans, strategies, future operations, and expected performance. These statements are based on current expectations and involve risks and uncertainties that may cause actual results to differ materially. Factors that could affect these results include, but are not limited to, market conditions and risks detailed in filings with the SEC. Investors are cautioned not to place undue reliance on forward-looking statements. Additional information is available at www.sec.gov.Media Contact: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:media@wellgisticshealth.com">media@wellgisticshealth.com</a> Investor Relations: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:investors@wellgisticshealth.com">investors@wellgisticshealth.com</a>Investor Relations Contact: Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, NY 10036 Office: (646) 893-5835 Email: <a target="_blank" rel="noopener noreferrer nofollow" href="mailto:info@skylineccg.com">info@skylineccg.com</a>SOURCE: Wellgistics Health, Inc.Note: This article has been published automatically by sourcing from Access Newswire. The Stocktwits editorial team did not edit this article.

Wellgistics Health (NASDAQ: WGRX) Launches XRP Payment Program for Independent Pharmacies

https://www.accessnewswire.com/newsroom/en/blockchain-and-cryptocurrency/wellgistics-health-nasdaq-wgrx-launches-xrp-payment-program-for-indep-1060334

Others

Wellgistics Health, Inc., a holding company focused on pharmaceuticals and healthcare services, has drawn significant retail investor attention since going public on Feb. 21.&nbsp;Despite closing below its $4.50 IPO price on day one, the Tampa, Florida-based company has seen its Stocktwits follower count surge by over 960%, with a six-fold increase in the last week alone, the highest for any healthcare firm on Stocktwits during this period.Message volume on the platform about the stock has also skyrocketed by 10,800% since its market debut.So, what's fueling the buzz? Let's break down the key developments since the IPO.Strategic Partnerships &amp; Product ExpansionLate last month, Wellgistics announced an agreement with Tollo Health to market its proprietary medical food products, addressing the side effects of GLP-1 treatments and long-term COVID-19.&nbsp;Tollo's flagship product, Galectovid, is designed to manage dietary Galectin-1 and 3-associated viral infections, muscle loss, and gut discomfort linked to GLP-1 drug use.Earlier this month, Wellgistics partnered with Protega Pharmaceuticals, the maker of Roxybond, an FDA-approved abuse-deterrent opioid pain medication.&nbsp;The collaboration aims to enhance pharmacist education on abuse-deterrent pain management and expand access to Roxybond, particularly in underserved rural areas, via Wellgistics' independent pharmacy clients.Leadership Change &amp; Compliance MilestoneEarlier this month, Wellgistics appointed Brian Norton as its new CEO, replacing Tim Canning. Under his leadership, the company plans to improve operational efficiency, optimize sales, advance its technology roadmap, and explore acquisition opportunities.Retail investors on Stocktwits took note of Norton's Fox Business&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.foxbusiness.com/video/6370288081112">interview</a> on Thursday, in which he said U.S. pharmacy benefit managers (PBMs) had failed to lower drug prices and instead led to rising costs.&nbsp;He said Wellgistics aims to address this by providing affordable medications and ensuring safe opioid administration.&nbsp;<stembedurl>https://stocktwits.com/Paraboljoker/message/608773239</stembedurl>Norton also advocated for scrutinizing PBMs, supporting independent pharmacies, and ensuring pricing transparency to empower patients.Since its Nasdaq debut in February, Wellgistics stock has climbed more than 8%, signaling strong investor confidence in the newcomer.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Why Retail Traders Are Rushing Into Small-Cap Wellgistics Health Weeks After Its Nasdaq Debut

The CEO has said the company aims to address the failures of pharmacy benefit managers by providing affordable medications and ensuring safe opioid administration.

Equity

The CEO has said the company aims to address the failures of pharmacy benefit managers by providing affordable medications and ensuring safe opioid administration.


Wellgistics Health, Inc. operates as a holding company centered around pharmaceuticals and healthcare services. Its business portfolio consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services. The company was founded by Ajjarapu Surendra on September 6, 2022 and is headquartered in Tampa, FL.

Current Price	$0.4335
Prev Close	$0.3995
Open	$0.40
Dividend Yield	N/A
50-Day Moving Average	$0.5708
Beta	0.00
Avg. Volume	497,148.82
PE Ratio	-0.39

52-Week High	$7.04
52-Week Low	$0.3357
Market Capitalization	$38.9M
EPS (Annual)	-$0.132
Price to Book	5.72
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

WGRX
Wellgistics Health Inc.

Feed

News

Sentiment

Fundamentals

Info

Latest WGRX News

WGRXWellgistics Health Inc.